X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (26) 26
clinical neurology (25) 25
index medicus (22) 22
neurosciences (22) 22
male (21) 21
female (20) 20
adult (18) 18
multiple sclerosis (18) 18
neurology (13) 13
middle aged (12) 12
medicine & public health (10) 10
neuroradiology (9) 9
adolescent (8) 8
conversion or distribution of electric power (8) 8
dynamo-electric machines (8) 8
electricity (8) 8
generation (8) 8
magnetic resonance imaging (8) 8
young adult (8) 8
therapy (7) 7
glatiramer acetate (6) 6
neurosurgery (6) 6
psychiatry (6) 6
retrospective studies (6) 6
fingolimod (5) 5
italy (5) 5
multiple sclerosis - drug therapy (5) 5
multiple sclerosis, relapsing-remitting - drug therapy (5) 5
natalizumab (5) 5
prevalence (5) 5
treatment outcome (5) 5
care and treatment (4) 4
child (4) 4
diagnostic-criteria (4) 4
disability (4) 4
disability evaluation (4) 4
disease (4) 4
interferon-beta (4) 4
nuclear magnetic resonance--nmr (4) 4
patients (4) 4
pregnancy (4) 4
recurrence (4) 4
research article (4) 4
risk factors (4) 4
aged (3) 3
alemtuzumab (3) 3
analysis (3) 3
article subject (3) 3
biology (3) 3
biotechnology & applied microbiology (3) 3
discontinuation (3) 3
disease-modifying drugs (3) 3
efficacy (3) 3
follow-up studies (3) 3
headache (3) 3
hospitals (3) 3
immunologic factors - adverse effects (3) 3
immunologic factors - therapeutic use (3) 3
immunology (3) 3
interferon (3) 3
medical research (3) 3
medicine (3) 3
multiple sclerosis - physiopathology (3) 3
multiple-sclerosis (3) 3
neoplasms. tumors. oncology. including cancer and carcinogens (3) 3
oncology (3) 3
photic stimulation (3) 3
postpartum relapses (3) 3
prospective studies (3) 3
stem cells (3) 3
time factors (3) 3
abridged index medicus (2) 2
activation (2) 2
age (2) 2
aged, 80 and over (2) 2
alemtuzumab - therapeutic use (2) 2
artifacts (2) 2
bioequivalence (2) 2
brain mapping (2) 2
brain neoplasms - pathology (2) 2
cell proliferation (2) 2
children (2) 2
classification (2) 2
clinical trials as topic (2) 2
cohort studies (2) 2
controlled phase-3 trial (2) 2
copemyl (2) 2
correction (2) 2
corticosteroids (2) 2
diagnosis (2) 2
disease progression (2) 2
double-blind (2) 2
drug therapy (2) 2
drugs (2) 2
exposure (2) 2
expression (2) 2
fetal outcomes (2) 2
genetic aspects (2) 2
genetics (2) 2
glatiramoid (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Multiple Sclerosis Journal, ISSN 1352-4585, 8/2019, Volume 25, Issue 9, pp. 1263 - 1272
Background: With many options now available, first therapy choice is challenging in multiple sclerosis (MS) and depends mainly on neurologist and patient... 
relapsing–remitting | persistence | Switch | naïve | disease modifying therapies | real-life | relapsing-remitting | NATALIZUMAB | NEUROSCIENCES | ADHERENCE | CLINICAL NEUROLOGY | COMORBIDITIES | DRUGS | INJECTIONS | FINGOLIMOD | naive | Intolerance | Spinal cord | Multiple sclerosis | Demography | Copolymer 1 | Nuclear magnetic resonance--NMR | Magnetic resonance imaging | Decision making | Interferon | Patients
Journal Article
Journal of Neurology, ISSN 0340-5354, 12/2018, Volume 265, Issue 12, pp. 2851 - 2860
Journal Article
Journal of Neurology, ISSN 0340-5354, 05/2018, Volume 265, Issue 5, pp. 1174 - 1183
Journal Article
Multiple Sclerosis Journal, ISSN 1352-4585, 8/2014, Volume 20, Issue 9, pp. 1265 - 1268
Journal Article
Neurology, ISSN 0028-3878, 05/2019, Volume 92, Issue 22, pp. e2527 - e2537
BACKGROUNDThe exclusion of other diseases that can mimic multiple sclerosis (MS) is the cornerstone of current diagnostic criteria. However, data on the... 
101
Journal Article
Journal of neurology, neurosurgery, and psychiatry, ISSN 0022-3050, 06/2019, p. jnnp-2019-320587
To study the effect of natural menopause on multiple sclerosis clinical course. This was an observational, retrospective, multicentre, cohort study. Menopause... 
Journal Article
Neurology, ISSN 0028-3878, 11/2017, Volume 89, Issue 22, pp. 2222 - 2229
Journal Article